Sign in
Stories
Stryker's Q1 2024 Success
Share
AVITA Medical to Announce 2023 Financial...
Accelus Strengthens Leadership with New ...
Advancements in Surgical Innovations
Afya Limited Expands Medical Seats in Br...
Akso Health Group's Expansion into Onlin...
Amgen's Weight-Loss Drugs Market Entranc...
Overview
API
Stryker, a leading medical technology company, reported a significant increase in its first quarter 2024 operating results. The consolidated net sales rose by 9.7% to $5.2 billion, driven by strong growth in MedSurg and Neurotechnology as well as Orthopaedics and Spine segments. The reported net earnings reached $788 million, with optimistic expectations for full-year 2024 results.
Ask a question
How might Stryker's strong performance impact its competitive position in the medical technology market?
In what ways could Stryker's projected full-year results influence investor confidence and strategic decision-making?
What factors contributed to the notable growth in MedSurg and Neurotechnology net sales compared to other segments?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Apr 2024
Coverage